Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. A. Rodriguez, G. Alcarraz, F. Gomez, S. Diaz, E. Gimeno, M. Reed, J. Roca, U. Günther, M. Cascante (Barcelona, Spain; Birmingham, United Kingdom). Training-induced effects on plasma metabolomics in patients with COPD. Eur Respir J 2008; 32: Suppl. 52, 2784

Member's Comments

No comment yet.

Related content which might interest you: Gender differences in plasma biomarkers levels in patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Proteomic analysis of plasma from COPD patients and smoking control subjects Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 The effects of high-flow oxygen on plasma endothelin-1 levels during exercise in advanced COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 403s Year: 2006 The effects of ELTGOL on muciciliary clearance in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 731s Year: 2006 Transcriptomic and epigenetic changes in the lung of patients with severe COPD Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Enoxaparin elicits an effect on lung function and blood gas levels in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 The complexities of patients with COPD Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II Year: 2014 Effect of nintedanib on blood biomarkers in patients with IPF in the INMARK trial Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 The effect of methylxanthine, corticosteroid, and N -acetylcystein on plasma oxidant/antioxidant levels in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Effects of BMI changes on lung function in COPD subjects from two longitudinal general population studies Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013